Former Pre-Seed Funding Company Receives Venture Capitol Investment

Tangent Medical Technologies, a recipient of Pre-Seed Capital Funding in 2010 through Ann Arbor SPARK, has recently secured 4.5 million in venture capital to bring their product to market. This funding will accelerate the commercialization of Tangent’s medical device, the NovaCath™, which is designed to replace the intravenous drug systems that are currently used in hospitals. Tangent’s history with SPARK dates back to 2009, when they participated... [Read More...]